TD Asset Management
PROF

TD Asset Management’s Profound Medical PROF Stock Holding History

TD Asset Management’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-124,300
Closed -$933K – 1260
2024
Q4 		$933K Hold
124,300
– – ﹤0.01% 1121
2024
Q3 		$989K Buy
+124,300
New +$1.12M ﹤0.01% 1187
2021
Q3 		– Sell
-19,662
Closed -$288K – 1550
2021
Q2 		$288K Buy
19,662
+2,021
+11% +$37.6K ﹤0.01% 1448
2021
Q1 		$354K Buy
17,641
+1,565
+10% +$37.5K ﹤0.01% 1438
2020
Q4 		$330K Buy
16,076
+2,980
+23% +$54.8K ﹤0.01% 1378
2020
Q3 		$230K Buy
+13,096
New +$208K ﹤0.01% 1328

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TD Asset Management's PROF Position: Q1 2025 in Review

TD Asset Management sold out of Profound Medical (PROF) in Q1 2025, closing a stake of 124,300 shares — an estimated $933K sold.

TD Asset Management first reported a position in PROF in Q3 2020 and held it in 6 quarters. The position peaked at $989K in Q3 2024. 49 funds tracked by Wall St. Rank hold PROF as of Q1 2025.

  • TD Asset Management reported no remaining Profound Medical position as of Q1 2025 after selling out during the quarter.
  • TD Asset Management sold 124,300 Profound Medical shares in Q1 2025, an estimated $933K.
  • TD Asset Management first reported a position in Profound Medical in Q3 2020 and held it in 6 quarters.
  • TD Asset Management's Profound Medical position peaked at $989K in Q3 2024.
  • 49 funds tracked by Wall St. Rank held Profound Medical as of Q1 2025.

Based on TD Asset Management's 13F filing for Q1 2025, filed 7 May 2025.